NUWAVE TECHNOLOGIES INC
10QSB, 1998-08-14
RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT
Previous: FIDELITY HOLDINGS INC, 10QSB, 1998-08-14
Next: JAKKS PACIFIC INC, 10QSB, 1998-08-14




       As filed with Securities and Exchange Commission on August 14, 1998

================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark one)
   [x]             Quarterly Report Pursuant to Section 13 or 15(d)
                       of the Securities Exchange Act of 1934

                    For the quarterly period ended June 30, 1998
                                         or

   [ ]            Transition Report Pursuant to Section 13 or 15(d)
                      of the Securities Exchange Act of 1934


          For the transition period from _______________ to _____________

                         Commission file number 0-28606

                            NUWAVE TECHNOLOGIES, INC.
        (Exact name of small business issuer as specified in its charter)

                Delaware                                22-3387630
     (State or other jurisdiction of        (I.R.S. Employer Identification No.)
     incorporation or organization)

One Passaic Avenue, Fairfield, New Jersey                 07004
(Address of principal executive offices)               (Zip Code)

         Issuer's telephone number, including area code: (973) 882-8810

         Check whether the issuer (1) has filed all reports required to be filed
by  Section  13 or 15(d)  of the  Securities  Exchange  Act of 1934  during  the
preceding 12 months (or such shorter period that registrant was required to file
such reports) and (2) has been subject to such filing  requirements for the past
90 days. Yes [x]  No [ ]

                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

         Check whether the registrant  filed all documents and reports  required
to be  filed  by  Section  12,  13 or  15(d)  of  the  Exchange  Act  after  the
distribution of securities under a plan confirmed by court. Yes [ ]   No [ ]

                      APPLICABLE ONLY TO CORPORATE ISSUERS

         State the number of shares  outstanding of each of the issuer's classes
of common equity, as of June 30, 1998: 8,358,515
                                       ---------

         Transitional Small Business Disclosure Format:    Yes [ ]    No [x]


================================================================================

<PAGE>

                            NUWAVE TECHNOLOGIES, INC.
                        (A Development Stage Enterprise)

                                   FORM 10-QSB

                                      INDEX

PART I - FINANCIAL INFORMATION

     ITEM 1.   CONDENSED FINANCIAL STATEMENTS

               Balance Sheet -   June 30, 1998 (unaudited)                 P. 3

               Statements of  Operations - For the three and six month
                   periods  ended June 30, 1997  (unaudited)  and June
                   30,  1998  (unaudited)  and for the period July 17,
                   1995 (inception) to June 30, 1998 (unaudited)           P. 4

               Statements of Cash  Flows - For the three and six month
                   periods  ended June 30, 1997  (unaudited)  and June
                   30, 1998  (unaudited)  and for the period from July
                   17, 1995 (inception) to June 30, 1998  (unaudited).     P. 5

               Notes to Condensed Financial Statements                     P. 7

     ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN 
               OF OPERATION                                                P. 10

PART II - OTHER INFORMATION

     ITEM 1.   LEGAL PROCEEDINGS                                           P. 19

     ITEM 2.   CHANGES IN SECURITIES AND USE OF PROCEEDS                   P. 19

     ITEM 3.   DEFAULTS UPON SENIOR SECURITIES                             P. 20

     ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS         P. 20

     ITEM 5.   OTHER INFORMATION                                           P. 21

     ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K                            P. 21

SIGNATURES                                                                 P. 22





                                  2


<PAGE>


                           NUWAVE TECHNOLOGIES, INC.
                        (A Development Stage Enterprise)


                                 Balance Sheet

                                     ASSETS


                                                                        June 30,
                                                                          1998
                                                                        --------
                                                                     (unaudited)

Current assets:

     Cash and cash equivalents                                     $ 6,832,277

     Inventory                                                          62,469

     Prepaid expenses and other current assets                         265,350
                                                                   -----------
                        Total current assets                         7,160,096

     Property and equipment                                            120,850

     Restricted Cash                                                   143,187

     Other assets                                                       95,077
                                                                   -----------
                         Total assets                              $ 7,519,210
                                                                   ===========
                                                                   


                      LIABILITIES AND STOCKHOLDERS' EQUITY


     Current liabilities:

          Accounts payable and accrued liabilities                 $   425,920
                                                                   -----------
                         Total liabilities                             425,920
                                                                   -----------

Commitments and contingencies

Stockholders'equity:

     Series A Convertible Preferred Stock, noncumulative,
     $.01 par value; authorized 400,000 shares; issued and
     outstanding - none

     Preferred stock, $.01 par value; authorized $1,000,000
     shares; issued and outstanding - none (Such preferences and
     rights to be designated by the Board of Directors)

     Common stock, $.01 par value; authorized 20,000,000 shares;
     as of June 30, 1998; issued and outstanding 8,358,515 shares.      83,585

     Additional paid in capital                                     18,232,759

     Deficit accumulated during the development stage              (11,223,054)
                                                                   ------------
                     Total stockholders' equity                      7,093,290
                                                                   ------------
                     Total liabilities and stockholders' equity    $ 7,519,210
                                                                   ===========


The  accompanying  notes  are an  integral  part of  these  condensed  financial
statements.


                                       3


<PAGE>


<TABLE>
<CAPTION>


                           NUWAVE TECHNOLOGIES, INC.
                        (A Development Stage Enterprise)


                            Statements of Operations
                                                                                                               Cumulative from
                                                                                                                July 17, 1995
                                     Three Months        Three Months        Six Months      Six Months           (inception)
                                        ended               ended              ended           ended                  to
                                       June 30,            June 30,           June 30,        June 30,             June 30,
                                         1997                1998               1997            1998                 1998
                                     ------------        ------------        ----------      ----------         ----------------
                                     (unaudited)          (unaudited)        (unaudited)     (unaudited)          (unaudited)
<S>                                  <C>                 <C>                 <C>             <C>              <C>            

Net Sales                                                                                                     $        10,275
Cost of Sales                                                                                                          (4,214)
                                     ------------        ------------        -----------     ----------         ----------------
                                                                                                                        6,061
                                     ------------        ------------        -----------     ----------         ----------------

Operating expenses:

Research and development expenses  $   (577,363)        $  (476,098)        $  (932,768)    $ (857,237)             (4,666,037)

General and administrative expenses    (598,847)           (709,439)         (1,291,054)    (1,240,596)             (5,802,827)
                                     ------------        ------------        -----------    ------------        ----------------
                                     (1,176,210)         (1,185,537)         (2,223,822)    (2,097,833)            (10,468,864)
                                     ------------        ------------        ------------   ------------        ----------------
          Loss from operations       (1,176,210)         (1,185,537)         (2,223,822)    (2,097,833)            (10,468,803)
                                     ------------        ------------        ------------   ------------        ----------------
Other income (expense):

          Interest income                52,552              43,987             117,613         64,335                 419,451

          Interest expense                                                                                           (331,542)
                                     ------------        ------------        ------------   ------------        ----------------
                                         52,552              43,987             117,613         64,335                  87,909
                                     ------------        ------------        ------------   ------------        ----------------

Net loss before extraordinary item   (1,123,658)         (1,141,550)         (2,106,209)    (2,033,498)            (10,374,894)

          Extraordinary item                                                                                          (848,160)
                                     ------------        ------------        ------------   ------------        ----------------

          Net loss                  $(1,123,658)        $(1,141,550)        $(2,106,209)   $(2,033,498)        $   (11,223,054)
                                     ============        ============        ===========    ============        ================

Basic and diluted loss per share:

      Weighted average number of
      common shares outstanding       5,348,334           6,818,182           5,338,278      6,156,281
                                     ============        ============        ===========    ============

      Basic and diluted loss 
      per share                     $     (0.21)        $     (0.17)        $     (0.39)   $     (0.33)
                                     ============        ============        ===========    ============


    The accompanying notes are an integral part of these condensed financial statements
</TABLE>



                                       4

<PAGE>

<TABLE>
<CAPTION>
                            NUWAVE TECHNOLOGIES, INC.
                        (A Development Stage Enterprise)

                            Statements of Cash Flows
                Increase (decrease) in cash and cash equivalents

                                                                                                                  Cumulative
                                                                                                                     from
                                                                                                                July 17, 1995
                                     Three Months        Three Months        Six Months      Six Months           (inception)
                                        ended               ended              ended           ended                  to
                                       June 30,            June 30,           June 30,        June 30,             June 30
                                         1997                1998               1997            1998                 1998
                                     ------------        ------------        ----------      ----------         ----------------
                                     (unaudited)          (unaudited)        (unaudited)     (unaudited)          (unaudited)
<S>                                  <C>                 <C>                 <C>             <C>                <C> 

Cash flows from operating activities:

     Net loss                        $ (1,123,658)       $ (1,141,549)       $ (2,106,209)   $ (2,033,497)      $ (11,223,054)

     Adjustments to reconcile net
     loss to net cash used in
     operating activities:

     Extraordinary item                                                                                               848,160

     Depreciation expense                  13,630              13,279              23,643          24,509              86,579

     Amortization of unamortized
     debt discount                                                                                                    168,778

     Amortization of deferred 
     financing costs                                                                                                   89,062

     Issuance of common stock
     for services rendered                                                                                             20,600

     Increase (decrease) in inventory                            2,055                              (2,651)           (62,469)

     Increase in prepaid expenses
     and other current assets            (107,286)            (164,836)          (105,313)        (154,345)          (265,350)

     Increase (decrease) in accounts
     payable and accrued liabilities       (5,749)             131,461           (137,668)         272,297            425,920

     Increase (decrease) in other
     assets                                12,266              (12,877)           (18,209)         (12,877)           (95,077)
                                      ------------           ----------          ---------        ---------           --------

          Net cash used in
          operating activities         (1,210,797)          (1,172,467)        (2,343,756)      (1,906,564)        (10,006,852)
                                      ============          ===========        ===========      ===========        ============

Cash flows from investing
activities:

     Purchase of property and
     equipment                            (45,367)             (20,481)           (66,073)         (41,888)           (207,429)
                                      ============          ===========        ===========      ===========        ============

          Net cash used in
          investing activities            (45,367)             (20,481)           (66,073)         (41,888)           (207,429)
                                      ============          ===========        ===========      ===========        ============

Cash flows from financing
activities:

     Proceeds from sales of 
     Series A Convertible
     Preferred Stock                                                                                                   900,000

     Proceeds from issuance of
     initial bridge units                                                                                              350,000

     Proceeds from issuance of 
     bridge units, net of exchange
     of initial bridge notes                                                                                         1,650,000

The accompanying notes are an integral part of these condensed financial statements

</TABLE>

                                        5
<PAGE>


<TABLE>
<CAPTION>

                            NUWAVE TECHNOLOGIES, INC.
                        (A Development Stage Enterprise)

                            Statements of Cash Flows
                Increase (decrease) in cash and cash equivalents

                                                                                                                  Cumulative
                                                                                                                     from
                                                                                                                July 17, 1995
                                     Three Months        Three Months        Six Months      Six Months           (inception)
                                        ended               ended              ended           ended                  to
                                       June 30,            June 30,           June 30,        June 30,             June 30
                                         1997                1998               1997            1998                 1998
                                     ------------        ------------        ----------      ----------         ----------------
                                     (unaudited)          (unaudited)        (unaudited)     (unaudited)          (unaudited)
<S>                                  <C>                 <C>                 <C>             <C>                <C> 

     Proceeds from IPO                                                                                             11,753,010

     Proceeds from equity offering
     - February 6, 1998                                                                       1,000,000             1,000,000

     Proceeds from Janssen Myers 
     equity offering May & June 1998                      7,280,546                           7,280,546             7,280,546

     Repayment of notes issued in 
     connection with initial bridge
     notes                                                                                                         (2,000,000)

     Costs incurred for equity
     offerings                                           (1,157,780)                         (1,294,230)           (3,642,812)

     Issuance of common stock in
     connection with exercise of 
     stock options                                                                46,668         23,332               100,000

     (Increase) decrease in
     restricted cash                  (278,001)              33,554             (278,001)        78,294              (143,187)

     Deferred financing costs                                                                                        (201,000)
                                    -----------          ----------           -----------    -----------             ---------
     Net cash provided (used
     in) by financing activities      (278,001)           6,156,320            (231,333)      7,087,942            17,046,557
                                    -----------          ----------           -----------    -----------             ---------
     Net increase (decrease)
     in cash and cash equivalents   (1,534,165)           4,963,372          (2,641,162)      5,139,489             6,832,277

Cash and cash equivalents at the
beginning of the period              4,950,944            1,868,905           6,057,941       1,692,788                 -
                                    -----------          ----------           -----------    -----------             ---------

     Cash and cash equivalents at
     the end of the period          $3,416,779           $6,832,277          $3,416,779      $6,832,277            $6,832,277
                                    ===========          ==========          ==========      ==========            ==========

Supplemental disclosure of cash
flow information:

     Interest paid during the
     period                                                                                                        $   73,702
                                                                                                                   ==========

Supplemental disclosure of non
     cash investing and financing
     activities:

Deferred financing costs incurred
in connection with the exchange of
the initial bridge notes for 14
bridge units                                                                                                       $  140,000
                                                                                                                   ==========

Deferred equity costs charged
     to additional paid in capital
     in connection with the PPO                                                                                    $   13,400
                                                                                                                   ==========
Deferred financing costs charged
     to additional paid-in capital in
     connection with the IPO                                                                                       $   25,000
                                                                                                                   ==========



600,000 Series A Convertible
     Preferred Stock converted
     into Common Stock                                                                                             $    6,000
                                                                                                                   ==========
The accompanying notes are an integral part of these condensed financial statements.

</TABLE>

                                        6


<PAGE>

                            NUWAVE TECHNOLOGIES, INC.
                        (A Development stage Enterprise)
                     NOTES TO CONDENSED FINANCIAL STATEMENTS


1.   Basis Of Interim Financial Statement Preparation

         The accompanying  unaudited  condensed  financial  statements have been
prepared in accordance with generally accepted accounting principles for interim
information.  Accordingly,  they  do not  include  all of  the  information  and
footnotes  required by generally  accepted  accounting  principles  for complete
financial statements. The results of operations for the interim periods shown in
this report are not  necessarily  indicative of expected  results for any future
interim  period or for the entire fiscal year.  NUWAVE  Technologies,  Inc. (the
"Company" or  "NUWAVE"),  a  development  stage  enterprise,  believes  that the
quarterly  information  presented  includes all adjustments  (consisting only of
normal,  recurring  adjustments) necessary for a fair presentation in accordance
with  generally  accepted  accounting  principles.  The  accompanying  condensed
financial  statements  should be read in conjunction  with the Company's  Annual
Report on Form 10-KSB as filed with the  Securities  and Exchange  Commission on
April 14, 1998.


2. Capital Transactions

         On February 6, 1998, the Company entered into a two-year agreement with
an investor  whereby the Company issued  253,485 shares of the Company's  common
stock,  par value $.01 per share  ("Common  Stock"),  for an aggregate  purchase
price of $1,000,000. In addition,  subject to certain conditions,  the agreement
provides  that,  from time to time over the life of the  agreement  the  Company
shall issue  "Puts" to the  investor  whereby the Company may issue for each Put
and the investor may purchase,  at the Company's option, shares of the Company's
Common  Stock for a minimum of  $250,000  and a maximum of  $750,000.  The total
aggregate  value of the Puts over the life of the agreement must be a minimum of
$1,000,000 and cannot exceed $5,000,000. The purchase price of the stock will be
at 88% of the  fair  market  value of the  stock  at the  time of the  Put.  The
following  restrictions,  among others,  apply beginning with the second Put: 1)
there must be 20 business days between Puts; 2) the average daily trading volume
in the Company's Common Stock for the 30 trading days prior to the Put date must
be at least 20,000  shares;  3) The minimum bid price for the  Company's  Common
Stock on the trading  day  immediately  preceding  the Put date must be at least
$2.50;  and 4) unless the investor  agrees  otherwise,  no Put can be made which
causes the  investor  to own more than 9.9% of the  Company's  then  outstanding
Common Stock.

         In connection  with the  agreement  the Company  issued to the investor
warrants to purchase an aggregate of 50,000 shares of Common Stock at a purchase
price of $6.41 per share and an additional warrant (the "supplemental  warrant")
to purchase an aggregate of 50,000 shares of Common Stock at a purchase price of
$3.95 per share.  The warrants may be exercised at any time beginning  August 6,
1998 and ending 3 years


                                       7
<PAGE>

                            NUWAVE TECHNOLOGIES, INC.
                        (A Development stage Enterprise)
            NOTES TO CONDENSED FINANCIAL STATEMENTS ---- (Continued)

thereafter.  The  supplemental  warrant may be exercised  at any time  beginning
April 19, 1998 and ending 5 years thereafter.

         On March 3, 1998, the Company entered into a consulting  agreement with
an  organization  (the   "Consultant")   whereby  the  Consultant  will  perform
consulting  services relating to corporate finance and other financial  services
matters. As compensation for such services, the Company shall pay the consultant
$5,000 per month  during an initial  term ending  September  3, 1999  subject to
automatic  one-year term extensions  unless either the Company or the Consultant
shall have given written notice at least 30 days prior to the end of the initial
or subsequent terms.

         In connection with this agreement, the Company issued to the Consultant
400,000 common stock purchase  warrants.  The warrants have an exercise price of
$4 and are exercisable  after September 3, 1999. The warrants expire on March 3,
2003.

         On May 11, 1998 the Company entered into a placement  agency  agreement
with the Consultant to act as the Company's  placement agent in a private equity
placement whereby the Company issued to certain accredited  investors as defined
under  Regulation D as promulgated  under the Securities Act of 1933, as amended
(the  "Securities  Act")  2,745,030  shares of the  Company's  Common  Stock and
2,058,801 Class A Redeemable Warrants  ("Warrant") between May 19, 1998 and June
6,  1998,  pursuant  to  six  closings,  for  an  aggregate  purchase  price  of
$7,280,546.  See Part II, Item 2,  (changes in  securities)  for a more detailed
description of the private  placement.  Each Warrant entitles the holder thereof
to purchase one share of common  stock at an exercise  price per share of $3.24,
subject to adjustment upon the occurrence of certain events to prevent dilution,
at any time  commencing  from June 6, 1998 and  expiring  on May 11,  2003.  The
Warrants are subject to  redemption  by the Company at $.01 per warrant after 12
months on not less than 30 days  prior  written  notice  to the  holders  of the
Warrants, provided the average closing bid price of the Common Stock has been at
least 250% of the then  current  exercise  price of the Warrants for a period of
thirty  consecutive days ending on the day prior to the day on which the Company
gives notice of redemption.  The Warrants will be exercisable until the close of
business on the day immediately preceding the date fixed for redemption.

         The Consultant  received for acting as placement agent, a commission of
10% ($728,055) of the gross proceeds from the sale of the Units, as well as a 3%
non-accountable  expense allowance  ($218,416) and reimbursement of other costs,
including legal expenses relating to the offering  ($77,171).  In addition,  the
Consultant received as part of its compensation,  warrants exercisable until May
11, 2003, to purchase up to (i) 688,084 shares of the Company's  Common Stock at
a price per share  ranging  from $2.55 to $3.06 and (ii) 516,068  warrants  (the
"Placement  Agent Warrant for Warrant") to purchase up to 516,068  shares of the
Company's Common Stock at a price per share of $3.24.


                                       8

<PAGE>

                            NUWAVE TECHNOLOGIES, INC.
                        (A Development stage Enterprise)
            NOTES TO CONDENSED FINANCIAL STATEMENTS ---- (Continued)

         As a result of the above capital  transactions  and in accordance  with
the provisions of that certain Warrant  Agreement dated as of July 3, 1996 ( the
"Public Warrant Agreement"),  between the Company, Rickel & Associates, Inc. and
American  Stock  Transfer  & Trust  Company,  adjustments  have been made to the
exercise price (the "Public  Warrant Price") for the warrants issued pursuant to
such Warrant  Agreement ( the "Public  Warrants") and to the number of shares of
Common Stock  issuable on exercise of the Public  Warrants.  The Public  Warrant
Price has been  reduced  from $5.50 to $4.15.  In  addition,  for every share of
Common Stock the Public  Warrant  holders were entitled to prior to the dilutive
transactions  (2,530,000 shares), the Public Warrant holders are now entitled to
1.325 shares of Common stock ( 3,352,250 shares).  Also,  pursuant to the Public
Warrant Agreement,  the Company can redeem the Public Warrants in the event that
the average closing price of the Company's  Common Stock is at least 150% of the
then current Public  Warrant Price for a period of 20 consecutive  trading days:
consequently,  the  average  closing  price now  required  is $6.225  versus the
original price of $8.25.

          Also, as a result of the above capital transactions  and in accordance
with the provisions of that certain Private Securities  Subscription  Agreement,
dated as of February 6, 1998, between Profutures Special Equities Fund, L.P. and
the Company, adjustments have been made to the exercise prices and to the number
of shares of Common Stock issuable on exercise of each of two warrants that were
issued pursuant thereto.  One warrant (the "Profutures  Warrant") had an initial
exercise  price of $6.41 per share (the  "Profutures  Warrant  Price") for up to
50,000 shares of Common Stock; the other warrant (the  "Supplemental  Profutures
Warrant") had an exercise price of $3.95 per share (the "Supplemental Profutures
Warrant  Price")  for up to 50,000  shares of Common  Stock.  As a result of the
above capital  transactions:  (i) the Profutures  Warrant Price has been reduced
from $6.41 to $4.61 and for every share of Common Stock the  Profutures  Warrant
holders were entitled to prior to the dilutive transactions (50,000 shares), the
Profutures  Warrant  holders are now  entitled to 1.390  shares of Common  Stock
(69,522  shares) and (ii) the  Supplemental  Profutures  Warrant  Price has been
reduced from $3.95 to $3.42 and for every share of Common Stock the Supplemental
Profutures  Warrant holders were entitled to prior to the dilutive  transactions
(50,000 shares), the Supplemental Profutures Warrant holders are now entitled to
1.155 shares of Common Stock (57,749 shares).

         On March 19, 1998, a director  exercised options with respect to 11,666
shares of Common Stock at $2.00 per share.






                                       9

<PAGE>

            MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION



Forward Looking Statements

         This Report on Form 10-QSB contains "forward-looking statements" within
the  meaning  of  Section  27A of the  Securities  Act  and  Section  21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements
other than  statements of historical  facts  included in this Report,  including
without  limitation,  the  statements  under  "General,"  "Marketing and Sales,"
"Research and Development,"  "Manufacturing," "Liquidity and Capital Resources,"
and "Plan of Operation" are  forward-looking  statements.  The Company  cautions
that  forward-looking  statements are subject to certain risks and uncertainties
that could cause actual results to differ materially from those indicated in the
forward-looking  statements, due to several important factors herein identified.
Important  factors that could cause  actual  results to differ  materially  from
those  indicated in the  forward-looking  statements  ("Cautionary  Statements")
include delays in product development, competitive products and pricing, general
economic conditions,  risks of intellectual property litigation,  product demand
and  industry  capacity,  new  product  development,  commercialization  of  new
technologies,  the Company's ability to raise additional  capital when required,
and the risk factors  detailed from time to time in the Company's  annual report
on Form  10-KSB and other  materials  filed  with the  Securities  and  Exchange
Commission ("SEC").

         All subsequent written and oral forward-looking statements attributable
to the Company or persons acting on its behalf are expressly  qualified in their
entirety by the Cautionary Statements.


General

         The Company, a development stage enterprise organized in July 1995, was
formed to develop, manufacture and market products which improve picture quality
image in set top boxes,  televisions,  VCR's, DVD's,  camcorders and other video
devices by enhancing and  manipulating  video  signals,  and to  facilitate  the
production of sophisticated  consumer and professional videos. In July 1996, the
Company  completed an initial  public  offering  ("IPO") of its Common stock and
Public  Warrants  from which it received net proceeds of  $9,538,428  and repaid
$2,000,000  principal amount of promissory notes issued in a previous financing.
On February 11, 1998, the Company received net proceeds of $915,000 for issuance
of 253,485  shares of its Common Stock to an  investor.  The Company also issued
warrants to purchase up to 100,000  shares of its Common Stock to such investor.
In addition the Company may issue "Puts" to the investor  over a two year period
whereby the investor  shall  purchase a minimum of $1,000,000 up to a maximum of
$5,000,000  of the  Company's  Common  Stock  (valued at 



                                       10

<PAGE>

88% of the  market  value  thereof)  Puts are for a minimum  of  $250,000  and a
maximum of $750,000 with certain restrictions applying beginning with the second
Put.. On May 11, 1998 the Company entered into a placement agency agreement with
Jansen-Meyers  Associates,  L.P. to act as the  Company's  placement  agent in a
private  equity  placement  whereby the Company issued  2,745,030  shares of the
Company's  Common Stock and 2,058,801  Warrants between May 19, 1998 and June 6,
1998 for an aggregate purchase price of $7,280,546.

         At the time of the IPO, the Company had produced working  prototypes of
the Initial  Products  (the  "Initial  products").  Subsequent  to the IPO,  the
Company  established  the Advanced  Engineering  Group to support the continuing
development of its products and related  technology,  and the  identification of
additional sources of new technology.  The Advanced Engineering Group is made up
of the Company's own  employees  and third party  consultants  who work with the
Company on a project by project basis. The Advanced  Engineering  Group operates
under the direction of the Vice  President-Marketing/Technical  Development. The
Company  has  used  its  Advanced  Engineering  Group  to  create  products  and
technology  independent of the "Licensed Products and Technology" as outlined in
the Exclusive  Worldwide  License  Agreement  entered into with Rave Engineering
Corporation  And the  Company on July 21,  1995 These  products  and  technology
include the NUWAVE Video  Processor  (the "NVP"),  a  significant  amount of the
software  included in each of its products and new circuitry to allow certain of
the  products to be  produced  as ASICs.  The  Advanced  Engineering  Group also
developed  the  Softsets  for the NVP and  certain  of the  enhancements  to it.
Utilizing this technology, the Company has developed the ProWave NVP 2.2 that is
currently  available  as a  stand-alone  unit or a PC board with  software.  The
Advanced  Engineering  Group is currently  developing a commercial  video retail
product also utilizing the NVP  technology  (the "retail  version").  During the
first half of 1997, the Company began  marketing the NVP and Softsets as well as
the NVP 2.2 as a stand-alone unit and as a PC board with software.

         The  Company  intends to produce the NVP in the form of an ASIC chip in
accordance with the customer's specific  application  requirements  supported by
firm  commitments   rather  than  producing  and  inventorying   ASIC  chips  in
anticipation  of  applications  required by  customers  in the  future.  In this
regard,  the Company  contracted  with Adaptive to provide  necessary  technical
support and manage this process under the Company's direction.  The Company also
contracted  with TEC to complete  the work  necessary  to convert the  Company's
current NVP PC board design to ASIC  specifications  and contracted with ZMD for
production of the ASIC. The Company  anticipates  the ASIC will be in production
during  the  second  half  of 1998  and has  entered  into a  multi-year  supply
agreement with Thomson for the purchase of the NVP ASIC chip.

         The Company has significantly scaled back its research and development,
and  marketing  and related  activities  with  respect to all other  existing or
proposed  products  in order  to  concentrate  its  resources  on the  continued
development and marketing of its Softsets and NVP products (i.e.,  ASIC chip for
the OEM market, the NVP 2.2 in the stand alone unit and PC board version for the
professional  video market and the consumer video retail  version).  The Company
believes  this  product  strategy  will 


                                       11

<PAGE>

allow it to take full  advantage  of the  growth  opportunity  presented  by the
converging PC, television, HDTV and telecommunication markets, which the Company
believes to be quite  significant.  The Company  anticipates  this strategy will
also  allow it to  conserve  its  resources  and at the same time  maximize  the
benefits to be derived from introducing these products into these converging and
expanding markets.

         As of June 30, 1998,  the Company had  accumulated a deficit during the
development  stage of  $11,223,054  which includes a net loss for the six months
ended June 30, 1998 of  $2,033,498.  The loss for the six months  ended June 30,
1998 included $1,240,596 in general and administrative expenses,  representing a
decrease of $50,458  compared to the six-month  period ended June 30, 1997. This
decrease included a reduction in sales and marketing costs of $314,226 discussed
more fully below and a $70,000 decrease in payments made to Prime  Technologies,
Inc.  pursuant to the  Exclusive  Agency  Agreement See  "Liquidity  and Capital
Resources" . Such decreases  were  substantially  offset by increases  resulting
from the Company's planned growth and expansion  including  increased  personnel
and  payroll  costs  ($35,609),  professional  and  legal  services  ($162,600),
insurance   costs   ($32,349),   investor   relations   ($44,906),   travel  and
entertainment  costs  ($28,915),  office  rent  ($9,032)  and  other  ($20,357).
Although  the Company  anticipates  deriving  some  revenue from the sale of its
proprietary  software (Softsets) and the NVP products within the next 12 months,
no assurance  can be given that these  products  will be  successfully  marketed
during  such  period.  Even if  revenues  are  produced  from  the  sale of such
products,  the Company expects to continue to incur losses for at least the next
12 months. See "Liquidity and Capital Resources."

Marketing and Sales

         In January 1998, the Company entered into a multi-year supply agreement
with  Thomson for the  purchase  of its NVP ASIC chip which the Company  expects
will be in production  during the second half of 1998. In  anticipation  of such
production,  the Company is currently  conducting sales presentations of the NVP
and Softsets to prospective OEM customers world wide (i.e.,  original  equipment
manufacturers  of  set  top  boxes,   televisions,   multimedia   computers  and
teleconferencing  equipment).  Although the Company is unable to predict whether
its  marketing  efforts will be  successful,  it believes that its products have
been well received.  The Company has increased the number of potential customers
who have signed  Confidentiality/Non-Disclosure  agreements with NUWAVE allowing
them to  expand  their  review  and  examination  of  NUWAVE's  exclusive  video
enhancement technology in order to evaluate its use in their products.

         In  addition,  in May 1998 the Company  opened a sales and  engineering
office in Osaka,  Japan to  maintain  on-going  discussions,  provide  in-person
demonstrations  of NUWAVE  technology and directly  participate in technical due
diligence sessions with potential  customers who are evaluating this technology.
NUWAVE  continues  to evaluate  the sales and  marketing  opportunities  for its
products and technology to be sold into the Chinese  domestic  market,  which is
equal to the size of the U.S. market.

                                       12

<PAGE>

         During  1997,  the Company  formed its ProWave  Division  for sales and
marketing of the NVP 2.2 and related products to the  professional  video market
(e.g.,  medical  imaging and security  surveillance  systems) and began  selling
limited  quantities   (primarily  for  demonstration   purposes)  of  its  first
commercial  product,  the NVP 2.2. Through June 30, 1998 four  organizations had
contracts to represent the Company's ProWave Division.  The Company is currently
in the process of adding  additional  representative  organizations to cover the
"high end" Home  Theater  market by calling on a very select  group of retailers
who are  members  of a national  organization  of  professionals  known as CEDIA
(Custom Electronic Design and Installation Association).

         The Company is currently developing retail products for those consumers
that have a TV and do not have a NUWAVE enabled  product but want to improve the
picture  quality of their home viewing.  These  products will be marketed by the
Company's CWave Division. The Company has determined that the most effective way
to introduce  this product  into the retail  marketplace  during 1999 is to work
through distributors who will manufacture and sell to retailers, including those
with whom they are  currently  doing  business.  The  Company  is  currently  in
discussions  with  several   distributors  and  hopes  to  establish   strategic
partnerships  to help expedite the  introduction  of the retail  products to the
market in 1999.

         During 1997, the Company contracted with professional sales consultants
to establish the development of the Company's sales organization  managed by the
Vice  President  of Sales.  In this  regard,  the  Company has  contracted  with
Competitive  Technologies,  Inc.  ("CTI")  to  assist it in the  development  of
NUWAVE's OEM business.  CTI, for over twenty six years, has been in the business
of  taking  R&D and  technology  companies  and  introducing  them to the  major
companies  specializing  in  their  respective  markets.  The  Company  also has
contracts  with  several  individuals  and  organizations  that  will  act  in a
commissioned sales representation capacity regarding the Company's products.

         During 1997, the Company had contracted  with a professional  marketing
communications firm to assist in the development and implementation of a program
to develop market awareness and commercialization of its products.  This program
included  development of Company and product  brochures and press kits,  product
specification  sheets,  development  of a Company  booth for use at trade shows,
attendance at key trade shows,  mailers,  the production of corporate videos for
use at sales  presentations,  development of and placement of  advertisements in
key industry journals,  etc. The developmental  costs relating to these programs
were  substantially  incurred during 1997 and as a result such  expenditures for
the first half of 1998 were reduced by  approximately  $314,226  compared to the
first  half of 1997.  During the  six-month  period  ended  June 30,  1998 costs
included $37,047 for professional  sales and marketing  consultants  compared to
$211,659 for the six-month  period ended June 30, 1997;  $76,595 for advertising
and public  relations  compared  to $169,097  for the six months  ended June 30,
1997;  and $6,646 for trade shows  compared to $53,760 for the six months  ended
June 30, 1997.  The Company is  continually  reviewing  its needs with a view to
maximizing efficiency while conserving its resources.


                                       13
<PAGE>

Research and Development

         Research and development activity with respect to the Company's Initial
Products was carried out by Rave prior to July 21, 1995, the date upon which the
Company  and  Rave  entered  into  the  License  Agreement  and the  Development
Agreement. The Company's Initial Products were based on technology originated by
Rave prior to the  Company's  organization  and  licensed to the Company by Rave
pursuant to the License  Agreement.  Although it was the Company's  intention to
utilize Rave as its primary source for research and development activities,  the
Company has been less than satisfied with the results of Rave's performance over
the life of the  Development  agreement  and has found it  necessary  to utilize
outside  engineering  sources as its primary means for product  development.  In
accordance with its terms,  the Development  Agreement will terminate on October
2, 1998.  The Company does not believe the  termination  of this  agreement will
have a materially  adverse  effect on its  operations  or ability to develop new
technology.

         The Company's Advanced Engineering Group utilizes the services of third
party  contractors in connection with its research and  development  activities.
The Company intends to continue to use outside consultants to assure exposure to
new ideas and technology and its Advanced Engineering Group to direct, supervise
and coordinate such efforts. The Company has used its Advanced Engineering Group
to create the NVP, to develop a significant  amount of the software  included in
each of its  products  and to  develop  new  circuitry  to allow  certain of the
products to be produced as ASICs.  In April 1997, it contracted with Adaptive to
assist in the ASIC development process. In November 1997, the Company contracted
with TEC to complete the ASIC design in  coordination  with  Adaptive  under the
supervision of the Company's Vice President of Marketing/Technical  Development.
The  Advanced  Engineering  Group also  developed  Softsets  and  certain of the
enhancements  to the NVP.  The Company  intends to use  members of the  Advanced
Engineering Group to assist it with the continued  development of the NVP in its
OEM and retail  versions  but  otherwise  significantly  reduce  its  research &
development activities for the Initial Products.

         From July 17, 1995 through June 30, 1998, the Company incurred expenses
of $4,666,037 on research and development,  of which  approximately 70% was paid
to Rave pursuant to the Development  Agreement.  During the next 12 months,  the
Company  intends to spend  approximately  $1,000,000 on research and development
and in support of the  commercialization  of its  products.  Of that  amount the
Company  estimates that  approximately  10% will be paid to Rave pursuant to the
Development  Agreement  and  approximately  90% will be  spent by the  Company's
Advanced Engineering Group for software development,  ASIC chip development, and
supervising and directing production engineering undertaken by third parties and
on  internal  research  and  development.  In the event the  Company  is able to
generate  sufficient revenues from sales of its Softsets and NVP products during
such  12-month  period,  it  anticipates  it will 


                                       14

<PAGE>

increase its expenditures on research and development and the  identification of
new sources of technology.

Manufacturing

         The Company does not contemplate that it will directly  manufacture any
of its products.  It intends to contract with third parties to  manufacture  its
proposed NVP and  Softsets.  It also may license to third  parties the rights to
manufacture the products,  either through direct licensing,  OEM arrangements or
otherwise.

         The Company intends to produce the NVP ASIC chip in accordance with the
customer's  specific  application  requirements  supported  by firm  commitments
rather  than  producing  and   inventorying   ASIC  chips  in   anticipation  of
applications  required by customers in the future.  In this regard,  the Company
contracted with Adaptive to provide necessary  technical support and manage this
process under the Company's direction,  contracted with TEC to complete the work
necessary  to  convert  the  Company's  current  NVP PC  board  design  to  ASIC
specifications  and contracted  with ZMD for production of the ASIC. The Company
anticipates  producing  the  initial  ASIC  during  the  second  half of 1998 in
accordance with the  requirements  of the Thomson supply  agreement and believes
that  this   initial  ASIC  will  be  readily   adaptable   to  other   customer
specifications, if required.

Employees

         The Company currently has eleven full-time  employees and, depending on
its level of business activity, expects to hire additional employees in the next
12 months, as needed, to support marketing and sales, manufacturing and research
and development.


Liquidity and Capital Resources

         From its  inception  until the IPO,  the Company  relied for all of its
funding  ($2,900,000 in cash plus the cancellation of the notes in the principal
amount of  $350,000)  on private  sales of its debt and equity  securities  (the
"Private Financings").  In July 1996, the Company completed its IPO and received
net proceeds of $9,538,428.  The Company used  $2,073,652 of the net proceeds of
the IPO to repay the principal and interest on the  outstanding  notes issued to
investors in connection with the Private Financings.

         On  February   11,   1998,   the  Company   received  net  proceeds  of
approximately  $915,000 from the sale of 253,485 shares of Common Stock pursuant
to an agreement with ProFutures Special Equities Fund, L.P. ("ProFutures") dated
February 6, 1998. The agreement  provides up to $5,000,000 in additional  equity
funding  under certain  terms and  conditions  (see Note 2 to Notes to Financial
Statements  -"Capital  Transactions").  Under  the  terms of the  agreement  the
Company has the right to draw up to  $5,000,000  in cash (in exchange for shares
of Common  Stock at a 12%  discount to market) at any time  through  February 6,
2000.  The  decision to make draws,  and the 


                                       15

<PAGE>

timing and amount of such draws are solely at the Company's discretion,  subject
to certain  conditions  beginning  with the second  Put;  however the Company is
required to draw a minimum of $1,000,000 by February 6, 2000.

         On May 11, 1998 the Company entered into a placement  agency  agreement
with Janssen-Meyers Associates,  L.P. ("Janssen-Meyers") to act as the Company's
placement  agent in a private  equity  placement  whereby the Company  issued to
certain accredited  investors as defined under Regulation D as promulgated under
the Securities Act of 1933, as amended (the  "Securities  Act") 2,745,030 shares
of the  Company's  Common  Stock  and  2,058,801  Class  A  Redeemable  Warrants
("Warrant") between May 19, 1998 and June 6, 1998, pursuant to six closings, for
an aggregate  purchase  price of  $7,280,546.  See Part II, Item 2,  (changes in
securities)  for a more detailed  description  of the private  placements.  Each
Warrant  entitles the holder thereof to purchase one share of common stock at an
exercise price per share of $3.24,  subject to adjustment upon the occurrence of
certain events to prevent dilution, at any time commencing from June 6, 1998 and
expiring on May 11, 2003.  The Warrants are subject to redemption by the Company
at $.01 per  warrant  after 12  months on not less  than 30 days  prior  written
notice to the holders of the Warrants, provided the average closing bid price of
the Common  Stock has been at least 250% of the then current  exercise  price of
the Warrants for a period of thirty  consecutive days ending on the day prior to
the day on which the Company  gives notice of  redemption.  The Warrants will be
exercisable  until the close of business on the day  immediately  preceding  the
date fixed for redemption.

         Janssen-Meyers  received for acting as placement agent, a commission of
10% ($728,055) of the gross proceeds from the sale of the Units, as well as a 3%
non-accountable  expense allowance  ($218,416) and reimbursement of other costs,
including legal expenses relating to the offering  ($77,171).  In addition,  the
Consultant received as part of its compensation,  warrants (the "Placement Agent
Warrants")  exercisable until May 11, 2003, to purchase up to (i) 688,084 shares
of the  Company's  Common Stock at a price per share ranging from $2.55 to $3.06
and (ii)  516,068  warrants  (the  "Placement  Agent  Warrant for  Warrant")  to
purchase up to 516,068 shares of the Company's Common Stock at a price per share
of $3.24.

         Pursuant  to the terms of the  License  Agreement  and the  Development
Agreement,  the Company has been paying Rave minimum monthly aggregate amount of
$65,000  to  maintain  the  exclusivity  under  the  license  agreement  and for
development fees under the Development agreement.  In accordance with its terms,
the  Development  Agreement  will  terminate  on October  2,  1998.  In order to
maintain exclusivity under the License Agreement, the Company may be required to
continue  to pay a  minimum  amount  of  $65,000  per  month for the term of the
License  agreement.  The Company is considering its options in this regard.  The
License  Agreement  also  provides for  additional  payments of $60,000 per year
through July 22, 1998 to be made to Rave for consulting  services to be rendered
to the  Company.  As of July 22,  1998 all such  payments  have been  made.  The
Development  Agreement  also  provides for Rave to receive  additional  payments
under certain conditions aggregating $850,000 to purchase or lease equipment for
use in developing the Licensed  Products and Technology,  if certain  conditions
were met. In this 


                                       16

<PAGE>

regard, on April 22, 1997, the Company deposited  $300,000 into a certificate of
deposit . The  certificate  of deposit  has been  pledged as  collateral  for an
irrevocable  standby letter of credit opened by the Company to guarantee monthly
equipment  lease  payments  (not to exceed  $23,611 per month) to be made by the
Company on behalf of Rave pursuant to the Development Agreement.  The balance of
the standby letter of credit has subsequently been reduced to $225,000.  Through
August 14, 1998, the Company had made payments of $314,660  against the $850,000
of equipment purchases in addition to the $300,000 guarantee of leases payments.
With the termination of the Development Agreement on October 2, 1998, management
does not expect the remaining expenditures of $235,340 to be required.

         The technology on which the Initial Products is based has been licensed
from  Rave  pursuant  to the  License  Agreement.  Pursuant  to the terms of the
License Agreement,  the Company is obligated to pay Rave royalties ("Royalties")
of (i) 2 1/2% of net  sales of  products  utilizing  Rave's  technology  ("Sales
Royalties"),  and (ii) 25% of any sublicensing fees received by the Company from
sublicenses  of the products  and  technology  covered by the License  Agreement
("Licensed Products and Technology").  Payments of Sales Royalties will commence
upon  the  earlier  of (i)  accumulated  net  sales  of  Licensed  Products  and
Technology sold by the Company or its future affiliates reaching an aggregate of
$50,000,000,  or (ii) the Company's aggregate net profits from sales of Licensed
Products and Technology equaling  $5,000,000.  As indicated earlier, the Company
has developed products and technology  independent of the "Licensed Products and
Technology" and believes that a substantial portion of its future sales will not
include the "Licensed Products and Technology".

         Pursuant to the terms of an  Exclusive  Agency  Agreement  (the "Agency
Agreement") dated as of July 21, 1995 between the Company and Prime,  Prime will
receive 35% of net sublicensing fees received by the Company with respect to the
first  $50,000,000  of aggregate net sales made by the  Company's  sublicensees,
after  subtracting the payments to Rave and licensing  expenses,  and thereafter
45%.  Prime  will  also  receive  up to an  additional  $1,500,000  of which (i)
$400,000  has been paid in  accordance  with the terms of the Agency  Agreement,
(ii) $400,000 is payable out of the Company's first sublicensing fees, and (iii)
$700,000 is payable out of the Company's portion of sublicensing  royalties when
net sublicensing sales exceed  $200,000,000.  The Agency Agreement only pertains
to the Licensed  Products and Technology  covered by the License  Agreement with
Rave. As indicated  earlier,  the Company has developed  products and technology
independent  of the  "Licensed  Products and  Technology"  and  believes  that a
substantial  portion of its future sales will not include the "Licensed Products
and Technology".

         The Company has  determined  to  concentrate  its resources and product
strategy on the sale of its Softsets and NVP products and  therefore the Company
anticipates   that  its  available  cash  will  be  sufficient  to  satisfy  its
contemplated cash requirements for at least through the next twelve months.


                                       17

<PAGE>

Plan of Operation

         The  Company's  plan of  operation  over  the  next 12  months  focuses
primarily on the final phase of the development of its ASIC chip,  marketing and
sales of its Softsets and NVP products in the OEM, professional video and retail
markets and the continued effort necessary to support the sales and marketing of
these products.

         The  Company  anticipates,  based on its  current  proposed  plans  and
assumptions  relating to its operations,  that it has sufficient cash to satisfy
the estimated cash  requirements  of the Company for the next 12 months from the
date of this document. In the event of unanticipated  expenses,  delays or other
problems  beyond this period the Company might be required to either utilize the
equity financing available under the terms of its agreement with ProFutures (see
Note 2 to Notes to  Financial  Statements - "Capital  Transactions")  or to seek
additional  funding  elsewhere.  In  addition,  in the  event  that the  Company
receives a larger  than  anticipated  number of  initial  purchase  orders  upon
introduction of Softsets and the NVP products,  it may require resources greater
than its available cash or than are otherwise  available to the Company. In such
event the Company may be required to raise additional  capital.  There can be no
assurance  that such  additional  capital  will be  available  to the Company if
needed, on commercially reasonable terms or at all.

         The  Company's  future  performance  will be  subject  to a  number  of
business factors, including those beyond the Company's control, such as economic
downturns and evolving  industry needs and preferences,  as well as the level of
competition and the ability of the Company to  successfully  market its products
and  technology.  There can be no  assurance  that the  Company  will be able to
successfully  implement a marketing strategy,  generate  significant revenues or
achieve  profitable  operations.  In addition,  because the Company has had only
limited  operations to date,  there can be no assurance  that its estimates will
prove to be accurate or that unforeseen events will not occur.

Year 2000

         The Company is  currently  addressing  a universal  situation  commonly
referred to as the "Year 2000  Problem".  The Year 2000  Problem  relates to the
inability  of certain  computer  software  programs  to properly  recognize  and
process date-sensitive  information relative to the year 2000 and beyond. During
1998,  the Company is devoting  the  necessary  resources to identify and modify
systems impacted by the Year 2000 Problem, or to implement new systems to become
year 2000 compliant in a timely  manner.  The cost of executing this plan is not
expected to have a material  impact on the  Company's  results of  operations or
financial  condition.  In addition the Company is contacting its major suppliers
and vendors to ensure their awareness of the Year 2000 Problem.  If the Company,
its suppliers or vendors are unable to resolve  issues  related to the year 2000
on a timely basis, it could result in a material financial risk.


                                       18

<PAGE>

                           PART II - OTHER INFORMATION

Item 1.  Legal Proceedings

         Not applicable

Item 2.  Changes in Securities

               As of May 11,  1998,  the  registrant  entered  into a  placement
         agency  agreement  (the  "Placement   Agreement")  with  Janssen-Meyers
         Associates,  L.P. ("JMA") whereby JMA agreed to act as the registrant's
         placement  agent in a private  placement  (the  "Offering")  to certain
         "accredited  investors,"  as defined under  Regulation D as promulgated
         under the Securities  Act of 1933, as amended (the "Act"),  of not less
         than 25 and not more than 70 Units (as defined  below) of the  Company,
         as such maximum number of Units may be increased by the Chief Executive
         Officer or Chief Financial  Officer of the Company.  Each Unit consists
         of (i) a number of shares of  common  stock,  par value  $.01 per share
         (the "Common  Stock"),  of the  registrant  determined  by dividing the
         purchase price per Unit of $100,000 by, for the initial  closing of the
         Offering,  $2.59, and, for each subsequent  closing,  the lesser of (x)
         $3.20 and (y) 80% of the "Average Closing Bid Price" which shall be the
         average   closing  bid  price  for  the  Common  Stock  for  the  eight
         consecutive trading days immediately preceding the date of a closing of
         the  Offering,  and  (ii)  Class  A  Redeemable  Warrants  to  purchase
         seventy-five  percent  (75%) of the number of shares of Common Stock of
         the registrant  determined in (i) above at an exercise price of $3.235.
         The  registrant  at its  discretion  may reject any  subscriptions  for
         Units.

               Under the Placement Agreement,  the Company agreed to pay to JMA,
         for its services as the placement  agent of the Units,  a commission of
         10% of the gross  proceeds from the sale of the Units,  as well as a 3%
         non-accountable  expense  allowance and  reimbursement for other costs,
         including legal expenses related to the Offering, subject to receipt by
         the Company of  appropriate  documentation.  The Company also agreed to
         grant to JMA warrants (the "Placement  Agent Warrants") to purchase 25%
         of the number of Units sold in the Offering,  exercisable until May 11,
         2003,  at a price  per Unit  equal to the  Offering  Price  per Unit of
         $100,000.

               On May 19, 1998 the initial  closing of the Offering  took place.
         The aggregate  subscription  amount was $5,070,483.41  resulting in the
         sale of 50.7 Units.  The per share  purchase price for the Common Stock
         was $2.59.  A total of 1,957,727  shares of Common Stock and  1,468,318
         Class A  Redeemable  Warrants  were  issued.  The net  proceeds  to the
         Company (net of payments to JMA and JMA's counsel) were $4,347,831.57.

               On May 21, 1998 the second  closing of the  Offering  took place.
         The aggregate subscription amount was $783,713.07 resulting in the sale
         of 7.837 Units.  The per share  purchase price for the Common Stock was
         $3.06.  A total of 256,120  shares of Common Stock and 192,093  Class A
         Redeemable  Warrants were issued.  The net proceeds to the Company (net
         of payments to JMA) were $681,831.37.

               On May 27, 1998 the third closing of the Offering took place. The
         aggregate  subscription  amount was  $625,900  resulting in the sale of
         6.259  Units.  The per share  purchase  price for the Common  Stock was
         $2.903.  A total of 215,613  shares of Common Stock and 161,713 Class A
         Redeemable  Warrants were issued.  The net proceeds to the Company (net
         of payments to JMA and JMA's counsel) were $535,896.75.

               On June 1, 1998 the fourth  closing of the  Offering  took place.
         The aggregate subscription amount was $273,750.00 resulting in the sale
         of 2.738 Units.  The per share  purchase price for the Common Stock was
         $2.61.  A total of 104,890  shares of Common  Stock and 78,667  Class A
         Redeemable  Warrants were issued.  The net proceeds to the Company (net
         of payments to JMA) were $237,389.50.

               On June 4, 1998 the fifth closing of the Offering took place. The
         aggregate  subscription amount was $201,700.00 resulting in the sale of
         2.017  Units.  The per share  purchase  price for the Common  Stock was
         $2.50.  A total of 80,680  shares of Common  Stock and  60,510  Class A
         Redeemable  Warrants were issued.  The net proceeds to the Company (net
         of payments to JMA) were $175,480.00.

               On June 9, 1998 the sixth and final  closing of the Offering took
         place. The aggregate  subscription amount was $325,000 resulting in the
         sale of 3.25 Units.  The per share  purchase price for the Common Stock
         was 


                                       19

<PAGE>

         $2.55.  A total of 130,000  shares of Common  Stock and 97,500  Class A
         Redeemable  Warrants were issued.  The net proceeds to the Company (net
         of payments to JMA and JMA's counsel) were $278,474.65.

               The aggregate  amount of the  subscriptions  for all six closings
         was  $7,280,546.48,  resulting  in the  sale of  72.801  units.  In the
         aggregate,  a total of 2,745,030  shares of Common Stock and  2,058,801
         Class A Redeemable  Warrants were issued. The aggregate net proceeds to
         the Company were $6,256,903.84.

               The  aggregate  amount for all six  closings  the Company paid to
         JMA, pursuant to the Placement Agreement, was $728,054.65 as commission
         and $218,416.39 as non-accountable  expense allowance. In addition, the
         Company  granted  to JMA,  in the  aggregate,  18.263  Placement  Agent
         Warrants to purchase 18.263 Units of the Company.

Item 3.  Defaults upon Senior Securities

         Not applicable

Item 4.  Submission of Matters to a Vote of Security Holders

         On June 23, 1998 the company held its annual meeting of stockholders to
         (i) elect directors, (ii) ratify amendments to the Company's 1996 Stock
         Incentive Plan for Employees and Consultants and to ratify the grant of
         stock options to the Named Executive Officers of the Company,  (iii) to
         ratify amendments to the Company's  Non-Employee  Director Stock Option
         Plan and to ratify the grant of stock  options to the  Directors of the
         Company and (iv) transact such other business as might be bought before
         the meeting.

         The  following  tables set forth  information  regarding  the number of
         votes cast for, against,  and abstentions,  with respect to each matter
         presented at the meeting.  Abstentions and broker-non votes are counted
         only for purposes of electing  directors in  accordance  with  Proposal
         One.

         (i)      Election of Directors
                                                       Against or
                  Nominee                For            Withheld     Abstentions
                  -------                ---            --------     -----------

                  Gerald Zarin        4,206,705          82,280           0
                  Edward Bohn         4,206,705          82,280           0
                  Lyle Gramley        4,206,705          82,280           0
                  David Kwong         4,206,705          82,280           0
                  Joseph Sarubbi      4,206,705          82,280           0

         (ii)     Ratification  of amendments to, 1996 Stock  Incentive Plan for
                  Employees and Consultants  and  ratification of grant of stock
                  options to the Named Executive Officers
         
                                                      Against or
                                         For           Withheld      Abstentions
                                         ---           --------      -----------

                                      3,620,539         646,181        22,265

         (iii)    Ratification of amendments to Company's  Non-Employee Director
                  Stock Option Plan and  ratification  of grant of stock options
                  to the Directors

                                                       Against or
                                         For            Withheld     Abstentions
                                         ---            --------     -----------

                                      3,630,339         636,941        21,705

         (iv)     No other business was transacted at the meeting


                                       20

<PAGE>

Item 5.  Other Information

         Not applicable

Item 6.  Exhibits and Reports on Form 8-K

         (a)   Exhibits

         *10.1    Placement Agency Agreement,  dated as of May 11, 1998, between
                  Janssen-Meyers Associates, L.P. and NUWAVE Technologies, Inc.

         *10.2    Escrow   Agreement,   dated  May  11,  1998,   between  NUWAVE
                  Technologies,   Inc.,  Janssen-Meyers  Associates,   L.P.  and
                  Republic National Bank of New York.

         *10.3    Warrant   Agreement,   dated  May  15,  1998,  between  NUWAVE
                  Technologies,   Inc.  and  American  Stock  Transfer  &  Trust
                  Company.

         *10.4    Form of Warrant Certificate.

         *10.5    Placement Agent Warrant Agreement, dated May 19, 1998, between
                  NUWAVE Technologies, Inc. and Janssen-Meyers Associates, L.P.

         *10.6    Form of Placement Agent Warrant Certificate.

         *10.7    Form of Subscription Agreement.


         27.      Financial data schedule

         *  Previously  filed  with the SEC as part of an 8-K filing on June 11,
            1998.


         (b)      Reports on Form 8-K

                  During the quarter  ended June 30, 1998,  a current  report on
                  Form 8-K with  respect  to Items 5 & 7 therein  was filed with
                  the Securities and Exchange Commission on June 11, 1998.




                                       21

<PAGE>

                                   SIGNATURES

         In accordance with the requirements of the Exchange Act, the Registrant
has caused this Quarterly  Report to be signed on its behalf by the undersigned,
thereunto duly authorized in the City of Fairfield in the State of New Jersey on
August 14, 1998.

                              NUWAVE TECHNOLOGIES, INC.
                              -------------------------
                                    (Registrant)


DATE:  August 14, 1998        By: /s/ Gerald Zarin
                                  ---------------------------------
                                  Gerald Zarin
_                             Chief Executive Officer and Chairman of the Board


DATE:  August 14, 1998        By: /s/ Jeremiah F. O'Brien
                                  ---------------------------------
                                  Jeremiah F. O'Brien
                                  Chief Financial Officer
                                  (Principal Financial Officer)



<TABLE> <S> <C>



<ARTICLE>                                5
<CIK>                                    0001009802
<NAME>                                   NUWAVE TECHNOLOGIES, INC.
<MULTIPLIER>                             1,000
       
<S>                                  <C>                    <C>
<PERIOD-TYPE>                              3-MOS                   3-MOS
<FISCAL-YEAR-END>                    DEC-31-1997             DEC-31-1997
<PERIOD-START>                       APR-01-1998             JAN-01-1998
<PERIOD-END>                         JUN-30-1998             MAR-31-1998
<CASH>                                     6,832                   1,869
<SECURITIES>                                   0                       0
<RECEIVABLES>                                  5                       6
<ALLOWANCES>                                   0                       0
<INVENTORY>                                   62                      65
<CURRENT-ASSETS>                           7,160                   2,034
<PP&E>                                       208                     187
<DEPRECIATION>                                87                      73
<TOTAL-ASSETS>                             7,519                   2,407
<CURRENT-LIABILITIES>                        426                     294
<BONDS>                                        0                       0
                          0                       0
                                    0                       0
<COMMON>                                      84                      56
<OTHER-SE>                                 7,009                   2,057
<TOTAL-LIABILITY-AND-EQUITY>               7,519                   2,407
<SALES>                                        0                       0
<TOTAL-REVENUES>                               0                       0
<CGS>                                          0                       0
<TOTAL-COSTS>                              1,186                     912
<OTHER-EXPENSES>                               0                       0
<LOSS-PROVISION>                               0                       0
<INTEREST-EXPENSE>                           (44)                    (20)
<INCOME-PRETAX>                                0                       0
<INCOME-TAX>                                   0                       0
<INCOME-CONTINUING>                       (1,142)                   (892)
<DISCONTINUED>                                 0                       0
<EXTRAORDINARY>                                0                       0
<CHANGES>                                      0                       0
<NET-INCOME>                              (1,142)                   (892)
<EPS-PRIMARY>                              (0.17)                  (0.16)
<EPS-DILUTED>                              (0.17)                  (0.16)
                                                


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission